D
BioVaxys Technology Corp. BIOV
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2024 04/30/2024 01/31/2024 10/31/2023 07/31/2023
Net Income -116.79% -204.17% 114.21% -27.51% -92.60%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 11,555.56% 101.27% -137.33% 7.06% 118.68%
Change in Net Operating Assets -643.33% -72.50% -74.56% 95.43% 432.98%
Cash from Operations 6.52% -17,988.89% 220.00% 91.57% 96.61%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 100.00% -- -- -- --
Cash from Investing 100.00% -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid 100.00% -- -- -- --
Issuance of Common Stock 1.14% -25.06% -- -- -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 7.08% -28.89% -- -- -100.00%
Foreign Exchange rate Adjustments -- 100.00% -136.84% 159.38% -220.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 140.74% -183.11% 178,425.00% 101.90% 33.96%
Weiss Ratings